N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine.
Anne Nathalia De Sousa-Silva, Clarissa de Almeida Moura, Carina Ioná De Oliveira Torres, Vitória Barros Marques, Jayane M Do Nascimento Silva, Bruno Lobão‐soares, Sérgio Ruschi B Silva, Nicole Galvão-Coelho, Fernanda Palhano-Fontes, Dráulio Barros de Araújo, Edilson Dantas Da Silva, Elaine C Gavioli
Neuropharmacology July 1, 2026 DOI: 10.1016/j.neuropharm.2026.110947 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal study Peer reviewed |
|---|---|
| Population | Male helpless mice (single-housed and group-housed) |
| Interventions | DMT S-ketamine |
| Dose | 10 or 25 mg/kg (ip) for DMT; 10 or 30 mg/kg (ip) for S-ketamine |
| Duration | Up to 8 days post-injection |
| Topics | Anxiety Depression 5-MeO-DMT DMT Esketamine Ketamine |
| Keywords | Animal models Mouse N,N-Dimethyltryptamine Psychedelics |
| Citations | 1 |
| Key points | DMT is as effective as S-ketamine in producing rapid and long-lasting antidepressant effects in helpless mice, and also shows anxiolytic-like effects. |
Abstract
N,N-dimethyltryptamine (DMT) is an naturally occurring indoleamine with hallucinogenic and antidepressant effects in humans. Here, we compared the effects of DMT and S-ketamine, a fast-acting antidepressant, in helpless mice. To induce helplessness, male single and group-housed mice were exposed to inescapable footshock stress; only helpless animals were subsequently treated with S-ketamine 10 or 30 mg/kg (ip), DMT 10 or 25 mg/kg (ip), or vehicle and tested in behavioral assays. In depressive-related behavioral tests, S-ketamine and DMT (both at 10 mg/kg), only in group-housed mice, 24 h after administration, reversed escape deficits and reduced escape latency in the learned helplessness model. In helpless single-housed mice, 5 days after drug administration, both compounds (at 10 mg/kg) prevented stress-induced anhedonia in the sucrose preference test. In the tail suspension test, DMT (10 mg/kg) reduced immobility up to 8 days post-injection, whereas the effects of S-ketamine (30 mg/kg) lasted up to 30 h after injection. In anxiety-related behavioral tests, DMT (10 mg/kg), but not S-ketamine, reversed stress-induced hypolocomotion in the open field test, and increased exploration in open arms in the elevated plus-maze up to 5 days post-administration. However, in the novelty-suppressed feeding behavior, at 8 days after drug administration, neither DMT nor S-ketamine altered mouse behavior. Collectively, DMT is as effective as S-ketamine in producing rapid and long-lasting antidepressant effects in helpless mice. Present data also suggest anxiolytic-like effects for DMT. Ultimately, main findings highlight the transdiagnostic therapeutic potential of DMT for stress-related disorders.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
DMT was as effective as S-ketamine in producing rapid and long-lasting antidepressant-like effects in helpless mice and also showed anxiolytic-like effects.
Synthesized
-
DMT was as effective as S-ketamine in producing rapid antidepressant effects, but only DMT reversed stress-induced anxiety-like behaviors in the open field and elevated plus-maze tests.
Synthesized
Comparable studies
Other preclinical and animal studies on DMT for depression, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression Adult male Sprague-Dawley rats | 2018 | Experimental study | |
| Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression. Wistar rats | 2025 | Randomized controlled trial | n = 126 |
| Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model. Male mice exposed to chronic unpredictable mild stress | 2026 | Preclinical animal study | |
| 5-Methoxy-N,N-Dimethyltryptamine: Functional Safety Pharmacology and Video-EEG Assessment of a Short-Acting Serotonergic Psychedelic in Beagle Canines. Beagle dogs | 2026 | Preclinical animal study | n = 11 |